Ambalal Sarabhai Enterprise last traded at ₹39.40 (2026-10-13). Over the past month the stock moved -4.3%, three months the stock moved +21.6%, year the stock moved +28.4%. Its closing range over 52 weeks is ₹25.01 – ₹48.00, with the latest close 17.9% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1977, Ambalal Sarabhai Enterprises Ltd is in the business of manufacturing Pharmaceuticals and Electronics[1]
Business Overview:[1] ASE is a pharmaceutical health care companies, which through its group companies, manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and abroad
In the latest quarter (Jun 2026), Ambalal Sarabhai Enterprise reported sales of ₹43.56 crore (+8.0%) and net profit of ₹3.98 crore (-51.6%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 43.56 | 4.55 | 10.45 | 3.98 | 0.52 |
| Mar 2026 | 65.49 | 5.70 | 8.70 | 6.50 | 0.85 |
| Dec 2025 | 52.00 | 4.08 | 7.85 | 3.64 | 0.47 |
| Sep 2025 | 44.45 | 0.36 | 0.81 | -0.56 | -0.07 |
| Jun 2025 | 40.34 | 1.46 | 3.62 | 8.22 | 1.07 |
| Mar 2025 | 64.81 | 5.30 | 8.18 | -0.27 | -0.04 |
| Dec 2024 | 45.97 | -0.70 | -1.52 | 2.23 | 0.29 |
| Sep 2024 | 44.70 | 2.54 | 5.68 | 2.62 | 0.34 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +11.7% | +6.6% | +19.2% | -0.9% | -0.6% | +13.1% | +1.0% | +8.0% |
| Operating profit growth | +151.5% | -127.7% | +14.0% | +210.6% | -85.8% | – | +7.5% | +211.6% |
| Net profit growth | +142.6% | +67.7% | -103.0% | +2248.6% | -121.4% | +63.2% | – | -51.6% |
| EPS growth | +142.9% | +70.6% | -103.4% | +2040.0% | -120.6% | +62.1% | – | -51.4% |
| OPM % | 5.7% | -1.5% | 8.2% | 3.6% | 0.8% | 7.9% | 8.7% | 10.5% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Ambalal Sarabhai Enterprise reported sales of ₹202.00 crore (+3.1%) and net profit of ₹18.00 crore (+260.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 202.00 | 12.00 | 6.00 | 18.00 | 2.32 |
| Mar 2025 | 196.00 | 9.00 | 5.00 | 5.00 | 0.64 |
| Mar 2024 | 173.00 | 6.00 | 3.00 | 6.00 | 0.74 |
| Mar 2023 | 170.00 | 8.00 | 5.00 | 11.00 | 1.49 |
| Mar 2022 | 197.00 | 25.00 | 13.00 | 47.00 | 6.16 |
| Mar 2021 | 163.00 | -2.00 | -1.00 | 29.00 | 3.83 |
| Mar 2020 | 133.00 | -3.00 | -2.00 | 14.00 | 1.83 |
| Mar 2019 | 150.00 | 6.00 | 4.00 | 4.00 | 0.55 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +20.0% | -11.3% | +22.6% | +20.9% | -13.7% | +1.8% | +13.3% | +3.1% |
| Operating profit growth | – | -150.0% | – | – | -68.0% | -25.0% | +50.0% | +33.3% |
| Net profit growth | +300.0% | +250.0% | +107.1% | +62.1% | -76.6% | -45.5% | -16.7% | +260.0% |
| EPS growth | +223.5% | +232.7% | +109.3% | +60.8% | -75.8% | -50.3% | -13.5% | +262.5% |
| OPM % | 4.0% | -2.0% | -1.0% | 13.0% | 5.0% | 3.0% | 5.0% | 6.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Ambalal Sarabhai Enterprise.
Get Free AI Stock Analysis FREE →Ambalal Sarabhai Enterprises consolidated net profit declines 51.58% in the June 2026 quarter - business-standard.com
Ambalal Sarabhai Enterprise shares were last quoted at ₹39.40 (-2.9% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Ambalal Sarabhai Enterprise has a price-to-earnings (P/E) ratio of 22.91 and a price-to-book (P/B) ratio of 1.92. The industry P/E is 53.33.
The 52-week high of Ambalal Sarabhai Enterprise is ₹49.98 and the 52-week low is ₹23.12.
The market capitalisation of Ambalal Sarabhai Enterprise is about ₹310.75 crore.
In the latest quarter (Jun 2026), Ambalal Sarabhai Enterprise reported sales of ₹43.56 crore (+8.0%) and net profit of ₹3.98 crore (-51.6%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Ambalal Sarabhai Enterprise has a 3-year ROE of 8.00%, 3-year profit growth of 17.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 31.36% of Ambalal Sarabhai Enterprise.
Ambalal Sarabhai Enterprise belongs to the Pharmaceuticals & Drugs sector.